Richard Nolan Townsend, CEO: Lexeo Therapeutics LXEO Sell · Filed 24/05/14

Trade details

Type: Insider sale
Amount: $66,100
Shares · price: 5,000 sh · $13.22 a share
Held after: 170,695 sh
Stock: Lexeo Therapeutics LXEO
Person: Richard Nolan TownsendCEO
Trade date: 24/05/13
Filed: 24/05/14
Days to filing: 1 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Lexeo Therapeutics trades, last 26 weeks

What else happened in Lexeo Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/13~24/06/12

Richard Nolan Townsend's recent trades

Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$16.6K
3,345 sh
$16.6K
Filed 08/18
Traded 08/18
Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$116.2K
25,947 sh
$116.2K
Filed 07/01
Traded 07/01
Richard Nolan TownsendCEO
SellLexeo Therapeutics
Sell
Lexeo Therapeutics
LXEO
$16.9K
3,342 sh
$16.9K
Filed 05/20
Traded 05/18
Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$16.9K
3,342 sh
$16.9K
Filed 05/18
Traded 05/18
Richard Nolan TownsendCEO
Sell10b5-1 planLexeo Therapeutics
Sell10b5-1 plan
Lexeo Therapeutics
LXEO
$313K
55,000 sh
$313K
Filed 04/07
Traded 04/06

Richard Nolan Townsend, CEO — sold $66.1K of Lexeo Therapeutics LXEO · 2.8% of holdings · 10b5-1 plan | Whalegun